Nonlinear Relationship Between Interleukin-6 and NT-proBNP at Admission in Hospitalized COVID-19 Patients

References

• Lai -C-C, Shih T-P, W-C K, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924.
   PubMed Web of Science ®Google Scholar
• Topol EJ. COVID-19 can affect the heart. Science. 2020;370(6515):408–409. doi:10.1126/science.abe2813
   PubMed Web of Science ®Google Scholar
• Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–848.
   PubMed Web of Science ®Google Scholar
• Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802–810. doi:10.1001/jamacardio.2020.0950
   PubMed Web of Science ®Google Scholar
• Ye L, Hu G, Yu H, Sun J, Yuan H. Metoprolol improves myocardial remodeling and cardiac function in patients with permanent pacemaker implantation. J Healthc Eng. 2022;2022:7340992. doi:10.1155/2022/7340992
   PubMed Web of Science ®Google Scholar
• McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7(6):429–442. doi:10.1038/nri2094
   PubMed Web of Science ®Google Scholar
• Rohleder N, Aringer M, Boentert M. Role of interleukin-6 in stress, sleep, and fatigue. Ann N Y Acad Sci. 2012;1261:88–96. doi:10.1111/j.1749-6632.2012.06634.x
   PubMed Web of Science ®Google Scholar
• Melendez GC, Mclarty JL, Levick SP, Du Y, Janicki JS, Brower GL. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension. 2010;56(2):225. doi:10.1161/HYPERTENSIONAHA.109.148635
   PubMed Web of Science ®Google Scholar
• Markousis-Mavrogenis G, Tromp J, Ouwerkerk W, et al. The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study. Eur J Heart Fail. 2019;21(8):965–973. doi:10.1002/ejhf.1482
   PubMed Web of Science ®Google Scholar
• Peng Y, Yang Q, Gao S, et al. IL-6 protects cardiomyocytes from oxidative stress at the early stage of LPS-induced sepsis. Biochem Biophys Res Commun. 2022;603:144–152. doi:10.1016/j.bbrc.2022.03.013
   PubMed Web of Science ®Google Scholar
• McGonagle D, Sharif K, O’Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6):102537. doi:10.1016/j.autrev.2020.102537
   PubMed Web of Science ®Google Scholar
• Pilut CN, Citu C, Gorun F, et al. The utility of laboratory parameters for cardiac inflammation in heart failure patients hospitalized with SARS-CoV-2 infection. Diagnostics. 2022;12(4):824. doi:10.3390/diagnostics12040824
   Web of Science ®Google Scholar
• Caro-Codón J, Rey JR, Buño A, et al. Characterization of NT-proBNP in a large cohort of COVID-19 patients. Eur J Heart Fail. 2021;23(3):456–464. doi:10.1002/ejhf.2095
   PubMed Web of Science ®Google Scholar
• Mueller C, McDonald K, de Boer RA, et al. Heart failure association of the European society of cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019;21(6):715–731. doi:10.1002/ejhf.1494
   PubMed Web of Science ®Google Scholar
• Sheth A, Modi M, Dawson D, Dominic P. Prognostic value of cardiac biomarkers in COVID-19 infection. Sci Rep. 2021;11(1):4930. doi:10.1038/s41598-021-84643-6
   PubMed Web of Science ®Google Scholar
• Qin -J-J, Cheng X, Zhou F, et al. Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19. Hypertension. 2020;76(4):1104–1112. doi:10.1161/HYPERTENSIONAHA.120.15528
   PubMed Web of Science ®Google Scholar
• Hara S, Sanatani T, Tachikawa N, et al. Comparison of the levels of neopterin, CRP, and IL-6 in patients infected with and without SARS-CoV-2. Heliyon. 2022;8(5):e09371. doi:10.1016/j.heliyon.2022.e09371
   PubMed Web of Science ®Google Scholar
• Talwar D, Kumar S, Acharya S, et al. Interleukin 6 and its correlation with COVID-19 in terms of outcomes in an intensive care unit of a rural hospital: a cross-sectional study. Indian J Crit Care Med. 2022;26(1):39–42. doi:10.5005/jp-journals-10071-24075
   PubMed Web of Science ®Google Scholar
• Giannitrapani L, Augello G, Mirarchi L, et al. Outcome predictors in SARS-CoV-2 disease (COVID-19): the prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population. J Infect. 2022;85:174–211. doi:10.1016/j.jinf.2022.04.043
   PubMed Web of Science ®Google Scholar
• Markousis-Mavrogenis G, Tromp J, Mentz RJ, et al. The additive prognostic value of serial plasma interleukin-6 levels over changes in brain natriuretic peptide in patients with acute heart failure. J Card Fail. 2021;27(7):808–811. doi:10.1016/j.cardfail.2021.01.008
   PubMed Web of Science ®Google Scholar
• Tøllefsen IM, Shetelig C, Seljeflot I, Eritsland J, Hoffmann P, Andersen G. High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI. Open Heart. 2021;8(2):824. doi:10.1136/openhrt-2021-001869
   Web of Science ®Google Scholar
• Velazquez-Salinas L, Verdugo-Rodriguez A, Rodriguez LL, Borca MV. The Role of Interleukin 6 During Viral Infections. Front Microbiol. 2019;10:1057. doi:10.3389/fmicb.2019.01057
   PubMed Web of Science ®Google Scholar
• Yang M-L, Wang C-T, Yang S-J, et al. IL-6 ameliorates acute lung injury in influenza virus infection. Sci Rep. 2017;7:43829. doi:10.1038/srep43829
   PubMed Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, Zhang J, Wang F. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respirat Medi. 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X
   PubMed Web of Science ®Google Scholar
• Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87(5):E1–9. doi:10.1161/01.RES.87.5.e1
   PubMed Web of Science ®Google Scholar
• Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004;94(12):1543–1553. doi:10.1161/01.RES.0000130526.20854.fa
   PubMed Web of Science ®Google Scholar
• Szabo-Fresnais N, Lefebvre F, Germain A, Fischmeister R, Signalling MP. A new regulation of IL-6 production in adult cardiomyocytes by beta-adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling. Cell Signal. 2010;22(7):1143–1152. doi:10.1016/j.cellsig.2010.03.009
   PubMed Web of Science ®Google Scholar
• Acharya S, Kumar S, Kabra R, et al. Impact of angiotensin receptor blocker as antihypertensive in assessing mortality in patients of COVID-19: a single tertiary care center study. J Educ Health Promot. 2023;12:30. doi:10.4103/jehp.jehp_922_22
   PubMedGoogle Scholar